Alvogen's Lotus Secures Deal With Fuji To Bolster Asia Presence

 
• By Grace Montgomery

Alvogen’s Taiwanese subsidiary Lotus has confirmed a cross-investment partnership with Fuji that will strengthen the firms’ commercial platform in Japan and other key Asian pharmaceutical markets.

Hiroshima
Alvogen and Fuji deal set to bolster presence in Asia, including Japan • Source: Shutterstock

More from Deals

More from Business